Top

Annual Report 2014/15Detailed Picture

Sub

Quarterly key figures

                 
EUR million 2014/15 2013/14
  Q4 Q3 Q2 Q1 Q4 Q3 Q2 Q1
Group                
Income statement                
Revenue 234 228 209 188 205 198 182 171
Gross profit 125 120 105 96 107 100 95 90
EBITDA before special items 86 77 66 57 75 68 58 56
Depreciation, amortization and impairment (13) (14) (14) (14) (14) (13) (13) (13)
EBIT before special items 73 64 53 44 62 55 45 43
EBIT 73 64 53 44 57 54 42 43
Net financial expenses (3) (2) (5) (3) (4) (3) (5) (3)
Profit before tax 70 62 48 40 53 51 37 40
Income taxes (18) (16) (12) (11) (15) (14) (10) (11)
Profit for the period 52 46 36 30 38 37 27 29
                 
Cash flow                
Cash flow from operating activities 111 72 55 (16) 94 55 45 (18)
Cash flow used for investing activities (25) (18) (14) (14) (21) (14) (13) (14)
Free cash flow 86 54 42 (30) 73 41 32 (31)
                 
Key ratios                
EPS, diluted 0.39 0.35 0.27 0.23 0.30 0.28 0.20 0.22
Organic growth, % 11 7 12 9 8 10 10 1
Gross margin, % 53.6 52.4 50.4 51.2 51.7 50.5 52.4 52.4
EBITDA margin before special items, % 36.8 33.9 31.7 30.3 36.6 34.2 31.9 32.5
EBIT margin before special items, % 31.1 28.0 25.2 23.1 30.0 27.8 24.8 25.2
EBIT margin, % 31.1 28.0 25.2 23.1 27.6 27.4 22.9 24.9
ROIC excl. goodwill, % 45.1 39.0 32.6 28.0 40.4 35.8 30.4 29.5
R&D, % 5.6 6.5 6.9 6.8 4.9 5.9 7.2 6.7
Capital expenditure, % 10.6 7.8 6.5 7.6 10.9 7.2 7.1 7.9
NWC, % 16.1 20.8 21.4 20.7 17.2 20.7 20.3 18.8
Net debt to EBITDA 1.7x 1.6x 1.8x 1.7x 1.6x 1.7x 1.8x 1.4x

 

Quarterly key figures by division

 
                 
EUR million 2014/15 2013/14
  Q4 Q3 Q2 Q1 Q4 Q3 Q2 Q1
Cultures & Enzymes Division                
Income statement                
Revenue 142 136 123 118 125 118 111 111
EBITDA 62 55 44 42 52 44 40 43
Depreciation, amortization and impairment (10) (10) (10) (10) (10) (9) (10) (9)
EBIT 53 45 34 32 42 35 30 34
                 
Key ratios                
EUR growth, % 14 15 11 7 5 3 5 (2)
Organic growth, % 12 8 9 7 8 10 12 4
EBITDA margin, % 43.6 40.1 35.5 35.5 41.7 37.0 35.7 38.7
EBIT margin, % 37.0 32.9 27.4 27.3 33.9 29.1 27.0 30.4
Invested capital excluding goodwill 408 426 419 413 419 425 410 408
ROIC excl. goodwill, % 50.4 42.4 32.4 31.6 40.0 32.9 29.8 33.6
                 
Health & Nutrition Division                
Income statement                
Revenue 45 43 44 32 40 36 36 24
EBITDA 19 16 18 11 17 16 13 6
Depreciation, amortization and impairment (2) (2) (2) (3) (2) (2) (2) (2)
EBIT 17 14 16 9 15 14 11 4
                 
Key ratios                
EUR growth, % 14 19 31 35 17 13 16 (6)
Organic growth, % 6 6 20 29 18 19 20 (1)
EBITDA margin, % 41.6 37.9 41.0 34.0 43.1 44.4 39.1 26.0
EBIT margin, % 36.3 32.8 35.9 26.3 37.4 38.6 33.0 17.5
Invested capital excluding goodwill 138 139 136 131 101 102 110 105
ROIC excl. goodwill, % 47.5 41.1 47.2 27.0 58.5 53.0 41.3 16.0
                 
Natural Colors Division                
Income statement                
Revenue 46 49 42 38 41 44 37 37
EBITDA 5 6 5 4 6 8 5 7
Depreciation, amortization and impairment (1) (2) (2) (2) (2) (1) (1) (1)
EBIT 4 5 3 3 5 7 4 5
                 
Key ratios                
EUR growth, % 13 12 13 3 (2) (2) (8) (10)
Organic growth, % 13 6 11 4 1 6 (2) (4)
EBITDA margin, % 11.1 13.0 10.7 11.1 14.9 18.4 14.2 18.2
EBIT margin, % 8.0 10.0 7.3 7.3 11.2 15.2 10.8 14.6
Invested capital excluding goodwill 86 92 96 94 84 90 91 87
ROIC excl. goodwill, % 16.7 21.0 12.9 12.8 21.1 26.1 22.8 26.7